WallStreetZenWallStreetZen

NASDAQ: SAGE
Sage Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Sage Therapeutics earnings were -$445.7M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest SAGE earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$102.9M, down 5.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, SAGE reported annual earnings of -$541.5M, with 1.6% growth. The next SAGE earnings date is Nov 5, 2024.

SAGE earnings history

Current Revenue
$97.2M
Current Earnings
-$445.7M
Current Profit Margin
-458.3%

SAGE Return on Equity

Current Company
-60.4%
Current Industry
22.8%
Current Market
33.7%
SAGE's Return on Equity (-60.4%)... subscribe to Premium to read more.
High Return on Equity Performance

SAGE Return on Assets

Current Company
-54.1%
Current Industry
3.5%
SAGE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SAGE announces earnings.

SAGE Return on Capital Employed

Current Company
-70.96%
Current Industry
21.3%
SAGE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SAGE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SAGE-$444.29M-$445.67MN/A-$7.41
VALNN/A-$35.23MN/A-$0.50
MNMD-$99.06M-$102.04MN/A-$2.26
TSHA-$109.55M-$114.34MN/A-$0.20
TBPH-$29.47M-$45.65MN/A-$0.94
View Top Biotech Stocks

SAGE earnings dates

Next earnings date
Nov 5, 2024

Sage Therapeutics Earnings Reports & History FAQ

What were Sage Therapeutics's earnings last quarter?

On SAGE's earnings call on Invalid Date, Sage Therapeutics (NASDAQ: SAGE) reported Q2 2024 earnings per share (EPS) of -$1.70, up 36.57% year over year. Total SAGE earnings for the quarter were -$102.85 million. In the same quarter last year, Sage Therapeutics's earnings per share (EPS) was -$2.68.

If you're new to stock investing, here's how to buy Sage Therapeutics stock.

When does Sage Therapeutics report earnings?

The next SAGE earnings call is Invalid Date. Add SAGE to your watchlist to be reminded of Sage Therapeutics's next earnings date.

Is Sage Therapeutics profitable or losing money?

As of the last Sage Therapeutics earnings report, Sage Therapeutics is currently losing money. Sage Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$445.67 million, a 24.67% decrease year over year.

What was SAGE's earnings growth in the past year?

As of Sage Therapeutics's earnings date in Invalid Date, Sage Therapeutics's earnings has grown year over year. SAGE earnings in the past year totalled -$445.67 million.

What are Sage Therapeutics's earnings expectations?

The current EPS estimate for Sage Therapeutics's earnings report in Invalid Date is -$1.55.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.